JosephJankovicMD

PubMed

• Systemic Symptoms in Huntington's Disease: A Comprehensive Review.
  Raja Mehanna, Joseph Jankovic> ;Movement Disorders Clinical Practice. 2024 Mar 26
• Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society members.
  Federico Rodriguez-Porcel, Harini Sarva, Juho Joutsa, Cristian Falup-Pecurariu, Aparna Wagle Shukla, Raja Mehanna, Katarzyna Śmiłowska, Giuseppe Lanza, Saša R Filipovi...> ;Journal of the Neurological Sciences. 2024 Mar 15
• Tics emergencies and malignant tourette syndrome: Assessment and management.
  José Fidel Baizabal-Carvallo, Andrea E Cavanna, Joseph Jankovic> ;Neuroscience and Biobehavioral Reviews. 2024 Apr 1
• Is Dystonia an Immunologic Disorder?
  Joseph Jankovic> ;Parkinsonism & Related Disorders. 2024 Feb 29
• CADASIL: A NOTCH3-associated cerebral small vessel disease.
  Yuan, L., Chen, X., Deng, H., Jankovic, J.> ;Journal of Advanced Research. 2024 Jan 2
• 1 citations
  Botulinum toxin treatment in parkinsonism.
  Anandan, C., Jankovic, J.> ;Journal of the Neurological Sciences. 2024 Jan 15
• Longitudinal predictors of health-related quality of life in isolated dystonia.
  Johanna Junker, James Hall, Brian D Berman, Marie Vidailhet, Emmanuel Roze, Tobias Bäumer, Irene A Malaty, Aparna Wagle Shukla, Joseph Jankovic, Stephen G Reich, Alber...> ;Journal of Neurology. 2024 Feb 1
• 3 citations
  Linking the cerebellum to Parkinson disease: an update.
  Tianbai Li, Weidong Le, Joseph Jankovic> ;Nature Reviews. Neurology. 2023 Nov 1
• Assessing the Severity of Cervical Dystonia: Ask the Doctor or Ask the Patient?
  Adam C Cotton, Laura Scorr, William McDonald, Cynthia Comella, Joel S Perlmutter, Christopher G Goetz, Joseph Jankovic, Laura Marsh, Stewart Factor, H A Jinnah> ;Movement Disorders Clinical Practice. 2023 Sep 1
• 1 citations
  Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension Study.
  Joseph Jankovic, Barbara Coffey, Daniel O Claassen, Joohi Jimenez-Shahed, Barry J Gertz, Elizabeth A Garofalo, David A Stamler, Maria Wieman, Juha-Matti Savola, Eran H...> ;Movement Disorders Clinical Practice. 2023 Sep 1
• Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impact.
  Joseph Jankovic, Joseph Tsui, Mitchell F Brin> ;Medicine. 2023 Jul 1
• 1 citations
  Spinal cord stimulation for gait disturbances in Parkinson's disease.
  Nora Vanegas-Arroyave, Joseph Jankovic> ;Expert Review of Neurotherapeutics. 2023 Jun 26
• 1 citations
  Real-world experience with VMAT2 inhibitors in Tourette syndrome.
  Joseph Jankovic, Makhoul, K.> ;Journal of Neurology. 2023 Sep 1
• 3 citations
  The role of the PLA2G6 gene in neurodegenerative diseases.
  Xinyue Deng, Lamei Yuan, Joseph Jankovic, Hao Deng> ;Ageing Research Reviews. 2023 Aug 1
• 8 citations
  COVID19-associated new-onset movement disorders: a follow-up study.
  Susanne A Schneider, Soaham Desai, Onanong Phokaewvarangkul, Elena Cecilia Rosca, Jirada Sringean, Pria Anand, Gary Álvarez Bravo, Francisco Cardoso, Anna M Cervantes-...> ;Journal of Neurology. 2023 May 1
• 1 citations
  Contrasting features between Tourette syndrome and secondary tic disorders.
  José Fidel Baizabal-Carvallo, Marlene Alonso-Juarez, Joseph Jankovic> ;Journal of Neural Transmission. 2023 Jul 1
• 8 citations
  Isolated Cervical Dystonia: Diagnosis and Classification.
  Alberto Albanese, Kailash P Bhatia, Francisco Cardoso, Cynthia Comella, Giovanni Defazio, Victor S C Fung, Mark Hallett, Joseph Jankovic, Hyder A Jinnah, Ryuji Kaji, J...> ;Movement Disorders. 2023 Aug 1
• Botulinum Neurotoxin Injections in Children with Self-Injurious Behaviors.
  Mariam Hull, Mered Parnes, Joseph Jankovic> ;Toxins. 2023 Mar 23
• 1 citations
  The Clinical Characterization of Blocking Tics in Patients With Tourette Syndrome.
  José Fidel Baizabal-Carvallo, Joseph Jankovic> ;Journal of Movement Disorders. 2023 May 1
• 2 citations
  Driving Impairment in Movement Disorders.
  Joseph Jankovic, Makhoul, K.> ;Movement Disorders Clinical Practice. 2023 Mar 1
• 1 citations
  How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson's disease?
  Abhishek Lenka, Joseph Jankovic> ;Expert Review of Neurotherapeutics. 2023 Feb 1
• Secondary dystonia following parenchymal brain tumors.
  José Fidel Baizabal-Carvallo, Joseph Jankovic> ;Journal of the Neurological Sciences. 2023 Mar 15
• 2 citations
  Oromandibular tics associated with Tourette syndrome.
  José Fidel Baizabal-Carvallo, Marlene Alonso-Juarez, Joseph Jankovic> ;Journal of Neurology. 2023 May 1
• 13 citations
  Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort.
  Eva-Juliane Vollstedt, Susen Schaake, Katja Lohmann, Shalini Padmanabhan, Alexis Brice, Suzanne Lesage, Christelle Tesson, Marie Vidailhet, Isabel Wurster, Faycel Hent...> ;Movement Disorders. 2023 Feb 1
• Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's D...
  Eva-Juliane Vollstedt, Harutyun Madoev, Anna Aasly, Azlina Ahmad-Annuar, Bashayer Al-Mubarak, Roy N Alcalay, Victoria Alvarez, Ignacio Amorin, Grazia Annesi, David Ark...> ;Plos One. 2023 Jan 1
• Join now to see all

Journal Articles

• Local Field Potentials of Subthalamic Nucleus Contain Electrophysiological Footprints of Motor Subtypes of Parkinson’s Disease  
  Joseph Jankovic, Ashwin Viswanathan, Akshay Gupte, Aviva Abosch, Proceedings of the National Academy of Sciences
• Dystonia treatment: Patterns of medication use in an international cohort  
  Pirio Richardson S, Wegele AR, Skipper B, Deligtisch A, Jinnah HA; Dystonia Coalition Investigators (including Jankovic J), Neurology, 1/1/2017
• Treatment of blepharospasm with apraclonidine  
  Vijayakumar D, Wijemanne S, Jankovic J, J Neurol Sci, 1/1/2017
• Letter re: Huntington disease reduced penetrance alleles occur at high frequency in the general population  
  Jankovic J, Squitieri F, Neurology, 1/1/2017
• Counseling at-risk Parkinson's disease cohorts: Integrating emerging evidence  
  Sokol LL, Young MJ, Jankovic J, Curr Genet Med Rep, 1/1/2017
• Research Priorities in Limb and Task-specific Dystonias  
  Pirio Richardson S, Altenmuller E, Alter K, Alterman RL, Chen R, Frucht S, Furuya S, Jankovic J, Jinnah HA, Kimberley TJ, Lungu C, Perlmutter JS, Prudente CN and Halle..., Front Neurol, 1/1/2017
• A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease  
  Olanow CW, Kieburtz K, Leinonen M, Elmer L, Giladi N, Hauser RA, Klepiskaya OS, Kreitzman DL, Lew MF, Russell DS, Kadosh S, Litman P, Friedman H, Linvah N, The P B Stu..., Mov Disord, 1/1/2017
• Metabolomic biomarkers as strong correlates of Parkinson disease progression  
  LeWitt PA, Li J, Lu M, Guo L, Auinger P; Parkinson Study Group–DATATOP Investigators (including Jankovic J), Neurology, 1/1/2017
• Movement disorders induced by deep brain stimulation  
  Baizabal-Carvallo JF, Jankovic J, Parkinsonism Relat Disord, 1/1/2016
• Genome-wide association study in essential tremoridentifies three new loci  
  Muller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, SotoOrtolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszo..., Brain, 1/1/2016
• Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials  
  Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K,..., JAMA Neurol, 1/1/2016
• Identification of TMEM230 mutations in familial Parkinson's disease  
  Deng HX, Shi Y, Yang Y, Ahmeti KB, Miller N, Huang C, Cheng L, Zhai H, Deng S, Nuytemans K, Corbett NJ, Kim MJ, Deng H, Tang B, Yang Z, Xu Y, Chan P, Huang B, Gao XP, ..., Nat Genet, 1/1/2016
• CSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study  
  Kang JH, Mollenhauer B, Coffey CS, Toledo JB, Weintraub D, Galasko DR, Irwin DJ, Van Deerlin V, Chen-Plotkin AS, Caspell-Garcia C, Waligorska T, Taylor P, Shah N, Pan ..., Acta Neuropathol, 1/1/2016
• How do I examine for a re-emergent tremor?  
  Jankovic J, Mov Disord Clin Practice, 1/1/2016
• Power calculations and placebo effect for future clinical trials in Progressive Supranuclear Palsy  
  Stamelou M, Schope J, Wagenpfeil S, del Ser T, Bang J, Lobach IY, Luong P, Respondek G, Oertel WH, Boxer AL, Hoglinger GU; for the AL-108-231 Investigators and Tauro..., Mov Disord, 1/1/2016
• Submolecular recognition regions of the H(N) domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients  
  Oshima M, Deitiker P, Jankovic J, Atassi MZ, J Neuroimmunol, 1/1/2016
• Progression of brain atrophy in PSP and CBS over 6 months and 1 year  
  Dutt S, Binney RJ, Heuer HW, Luong P, Attygalle S, Bhatt P, Marx GA, Elofson J, Tartaglia MC, Litvan I, McGinnis SM, Dickerson BC, Kornak J, Waltzman D, Voltarelli L, ..., Neurology, 1/1/2016
• Recent advances in understanding and managing Tourette syndrome  
  Thenganatt MA Jankovic J, F1000Research, 1/1/2016
• Leg stereotypy disorder  
  Jankovic J, J Neurol Neurosurg Psychiatry, 1/1/2016
• Psychogenic ophthalmologic movement disorders  
  Baizabal-Carvallo JF, Jankovic J, J Neuropsychiatry Clin Neurosci, Summer, 1/1/2016
• Data analytics from Enroll-HD, a global clinical research platform for Huntington’s disease  
  Landwehrmeyer GB, Fitzer-Attas CJ, Giuliano JD, , AB, BSN,2 Alves NG, Anderson KE, Cardoso F, Ferreira JJ, Mestre TA, Stout JC, Sampaio C (including Jankovic J), Mov Disord Clin Practice, 1/1/2016
• Dystonia Genetic Consortium Clinical and genetic features of cervical dystonia in a large multicenter cohort  
  LeDoux MS, Vemula SR, Xiao J, Thompson MM, Perlmutter JS, Wright LJ, Jinnah JA, Rosen AR, Hedera P, Comella CL, Weissbach A, Jankovic J, Barbano RL, Reich SG, Rodrigue..., Neurol Genet, 1/1/2016
• The relationship between essential tremor and Parkinson’s disease  
  Thenganatt MA, Jankovic J, Parkinsonism Relat Disord, 1/1/2016
• Deutetrabenazine in tics associated with Tourette syndrome  
  Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D, Tremor Other Hyperkinet Mov, 1/1/2016
• Bolivian kindred with combined spinocerebellar ataxia types 2 and 10  
  Baizabal-Carvallo JF, Xia G, Botros P, Laguna J, Ashizawa T, Jankovic J, Acta Neurol Scand, 1/1/2015
• Join now to see all

Books/Book Chapters

• Bradley’s Neurology in Clinical Practice 
  Chapter: Diagnosis of Neurological Disease. Chapter 1. 
  Page 1 - 7Daroff RB, Jankovic J, Mazziota JC, Pomeroy SLEditors: Daroff RB, Jankovic J, Maziotta J, Pomeroy S.Butterworth-Heinemann (Elsevier), Philadelphia, PAEdition 7th,2016
• Neurology secrets 
  Chapter: Basal ganglia disorders. 
  Page 137 - 148Wijemanne S, Hanna PA, Jankovic JEditors: Kass JS, Mizrahi EM.Elsevier, Philadelphia, PAEdition 6th,2016
• Neurology secrets 
  Chapter: Movement disorders. 
  Page 149 - 166Wijemanne S, Hanna PA, Jankovic JEditors: Kass JS, Mizrahi EM.Elsevier, Philadelphia, PAEdition 6th,2016
• Bradley’s Neurology in Clinical Practice 
  Chapter: Diagnosis and Assessment of Parkinson’s Disease and Other Movement disorders. Chapter 23 
  Page 223 - 249Jankovic J, Lang AEEditors: Daroff RB, Jankovic J, Maziotta J, Pomeroy S.Butterworth-Heinemann (Elsevier), Philadelphia, PAEdition 7th,2016
• Functional Neurologic Disorders, Handbook of Clinical Neurology 
  Chapter: Psychogenic (functional) parkinsonism. 
  Page 259 - 262Thenganatt MA, Jankovic JEditors: Hallett M, Stone J, Carson A.Elsevier, Amsterdam, Netherlands2016
• Bradley’s Neurology in Clinical Practice 
  Chapter: Laboratory Investigations in Diagnosis and Management of Neurological Disease. Chapter 33. 
  Page 1422 - 1460Daroff RB, Jankovic J, Mazziota JC, Pomeroy SLEditors: Daroff RB, Jankovic J, Maziotta J, Pomeroy S.Butterworth-Heinemann (Elsevier), Philadelphia, PAEdition 7th,2016
• Movement Disorders in Childhood 
  Singer HS, Mink JW, Gilbert DL, Jankovic JButterworth-Heinemann (Elsevier), Philadelphia, PAEdition 2nd,2016
• Bradley’s Neurology in Clinical Practice, Volume 1 and 2 
  Jankovic JEditors: Daroff RB, Jankovic J, Maziotta J, Pomeroy S.Butterworth-Heinemann (Elsevier), Philadelphia, PAEdition 7th,2016
• Medication-Induced Movement Disorders 
  Chapter: L-dopa dyskinesias. 
  Page 110 - 130Ramirez-Castaneda J, Jankovic JEditors: Friedman J.Cambridge University Press2015
• Merritt’s Textbook of Neurology 
  Chapter: Choreas. 
  Page 691 - 697Jankovic J, Fahn S.Editors: Louis E, Mayer S, Rowland LP.Wolters Kluwer/Lippincott Williams & WilkinsEdition 13th,2015
• Movement Disorders: Genetics and Models 
  Chapter: Tics and Tourette syndrome: Phenomenology. 
  Page 705 - 712Patel N, Jankovic JEditors: Ledoux MS.Elsevier, ElsevierEdition 2nd,2015
• Parkinson's Disease and Movement Disorders 
  Editors: Jankovic J, Tolosa E.Lippincott Williams & Wilkins, Philadelphia, PAEdition 6th,2015
• Movement Disorders in Neurologic and Systemic Disease 
  Chapter: Principles of management in movement disorders. 
  Page 31 - 38Poewe W, Jankovic JEditors: Poewe W, Jankovic J.Cambridge University Press, Cambridge, United Kingdom2014
• Movement Disorders in Neurologic and Systemic Disease 
  Chapter: Movement disorders of autoimmune origin. 
  Page 52 - 72Baizabal-Carvallo JF, Jankovic JEditors: Poewe W, Jankovic J.Cambridge University Press, Cambridge, United Kingdom2014
• Movement Disorders in Neurologic and Systemic Disease 
  Chapter: Phenomenology, classification and diagnostic approach to patients with movement disorders. 
  Aerts MB, Jankovic J, van de Warrenburg BP, Bloem BREditors: Poewe W, Jankovic J.Cambridge University Press, Cambridge, United Kingdom2014
• Geriatric Neurology 
  Chapter: Parkinson’s disease. 
  Page 315 - 324Fekete R, Jankovic JEditors: Sabbagh MN and Nair AK.Wiley2014
• Movement Disorders in Neurologic and Systemic Disease 
  Chapter: Respiratory complications of movement disorders. 
  Page 398 - 418Mehanna R, Jankovic JEditors: Poewe W, Jankovic J.Cambridge University Press, Cambridge, United Kingdom2014
• Handbook of Neurotoxicity 
  Chapter: Botulinum neurotoxins as therapeutics. 
  Page 553 - 590Mehanna R, Jankovic JEditors: Kostrzewa R.Springer Science Publishing2014
• Movement Disorders in Neurologic and Systemic Disease 
  Editors: Poewe W, Jankovic J.Cambridge University Press, Cambridge, United Kingdom2014
• Movement Disorders, Current Opinion in Neurology 
  Editors: Jankovic J.Wolters Kluwer Health/ Lippincott Williams & Wilkins, London, United Kingdom2014
• Parkinson's Disease: Diagnosis, Motor Symptoms and Non-Motor Features. Clinical Insights E-Book Series 
  Chapter: Animal models of Parkinson’s disease. 
  Page 115 - 136Le W, Jankovic JEditors: Jankovic J.Future Science Group, London, United Kingdom2013
• Parkinson's Disease: Diagnosis, Motor Symptoms and Non-Motor Features. Clinical Insights E-Book Series 
  Chapter: Differentiating Parkinson’s disease from other parkinsonian disorders. 
  Page 137 - 141Jankovic JEditors: Jankovic J.Future Science Group, London, United Kingdom2013
• Parkinson’s Disease: Medical and Surgical Treatment. Clinical Insights E-Book Series 
  Chapter: Parkinson’s disease treatment pipelines. 
  Page 138 - 148Jankovic JEditors: Jankovic J.Future Science Group, London, United Kingdom2013
• Manual of Botulinum Toxin Therapy 
  Chapter: The use of botulinum toxin in tic disorders and essential hand and head tremor. 
  Page 160 - 167Jankovic JEditors: Truong D, Dressler D, Hallett M.Cambridge University Press2013
• Movement Disorders: 101 Challenging Cases 
  Chapter: Dystonia, ataxia, dementia and a family history of “Huntington disease”. 
  Page 187 - 190Jankovic JEditors: Fernandez H, Merello M.Demos Medical, New York, NY2013
• Join now to see all

Abstracts/Posters

• A pilot study of deutetrabenazine in tics associated with Tourette syndrome.
  Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D, American Society of Clinical Psychopharmacology, Miami Beach, FL, 1/29/2017
• Results from a phase 1b multiple ascending-dose study of PRX002, an anti–alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease.
  Jankovic J, Goodman I, Safirstein B, Schenk D, Kinney GG, Koller M, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaa..., 3rd EAN Congress, Amsterdam, The Netherlands, 1/27/2017
• A phase 2, openlabel, dose-escalating study to evaluate the safety and preliminary efficacy of daxibotulinumtoxinA for injection (RT002) in isolated cervical dystonia.
  Comella CL, Brashear A, Jankovic J, Patel AT, Truong DD, Chung CY, Rubio RG, 69th Annual Meeting of the AAN, Boston, MA, 1/22/2017
• Clinical relevance of treatment with onabotulinumtoxinA in patients with cervical dystonia: Results from the CD Probe study.
  Mari Z, Dashtipour K, Jankovic J, Adler CH, Schwartz M, Brin MF, 69th Annual Meeting of the AAN, Boston, MA, 1/22/2017
• Assessment of capacity to consent in a Huntington disease clinical trial: Implications for future clinical trial design in neurodegenerative disease populations.
  Testa C, Edmondson M, Agarwal P, Blindauer K, Gray C, Jankovic J, Kumar R, Shprecher D, Siragusa P, Whaley J, Frank S for the Huntington Study Group First-HD and ARC-H..., 69th Annual Meeting of the AAN, Boston, MA, 1/22/2017
• A phase 2, openlabel, dose-escalating study to evaluate the safety and preliminary efficacy of Daxibotulinumtoxina for injection (RT002) in isolated cervical dystonia.
  Comella CL, Brashear A, Jankovic J, Patel AT, Truong DD, Chung CY, Rubio RG, 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/8/2017
• Clinical relevance of treatment with onabotulinumtoxina in patients with cervical dystonia: results from the CD PROBE study.
  Dashtipour K, Mari Z, Jankovic J, Adler CH, Schwartz M, Brin MF, 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/8/2017
• A randomized, double-blind, placebo-controlled study of the D1 receptor antagonist ecopipam for children and adolescents with Tourette syndrome.
  Gilbert DL, Murphy T, Jankovic J, Budman CL, Black KJ, Kurlan R, Coffman KA, McCracken J, Juncos J, Grant J, and Chipkin RE, 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/8/2017
• Leg stereotypy disorder: Clinical characteristics and prevalence.
  Jankovic J, Lotia M, York MK, Strutt AM, 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/7/2017
• Emotion regulation and cognitive functioning in psychogenic patients.
  Scott BM, Strutt AM, Lundberg-Love P, Schmitt AL, Jankovic J, Bowers D, 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/7/2017
• Whole exome sequencing in essential tremor.
  Alfradique-Dunham I, Robak LA, Kaw A, Fagbongbe OI, Coban Akdemir Z, Young E, Lupski J, Jankovic J, Shulman JM, 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/6/2017
• Treatable rare movement disorders.
  Rare Movement Disorders Study Group (Jankovic J), 21st International Congress of Parkinson’s Disease and Movement Disorders, Vancouver, Canada, 1/6/2017
• Hemidystonia associated with Alexander disease.
  Vijayakumar D, Lewis RA, Fuller GN, Dhar SU, Machol K, Robak L, Jankovic J, 21st International Congress of Parkinson's Disease and Movement Disorders, Vancouver, Canada, 1/6/2017
• Results from a phase 1b multiple ascending-dose study of PRX002, an anti–alpha-synuclein monoclonal antibody, in patients with Parkinson’s disease.
  Jankovic J, Goodman I, Safirstein B, Schenk D, Kinney GG, Koller M, Ness DK, Griffith SG, Grundman M, Soto J, Ostrowitzki S, Boess FG, Martin-Facklam M, Quinn JF, Isaa..., Neurodegener Dis; 13th International Conference on Alzheimer’s and Parkinson’s Disease, Vienna, Austria, 1/1/2017
• A pilot study of deutetrabenazine in tics associated with Tourette syndrome.
  Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D, 63rd Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York, NY, 1/27/2016
• Movement Disorders. Objectives of the rare movement disorders study group.
  Gatto EM, Albanese A, Bathia K, Cardoso F, Cesarini M, Chade A, Chana P, De la Cerda A, Espay A, Etcheverry J, Ferreira J, Garcia Ruiz P, Jankovic J, Jinnah HA, Kaji R..., 20th International Congress of Parkinson’s Disease and Movement Disorders, Berlin, Germany, 1/23/2016
• Predictors of onabotulinumtoxinA treatment response in patients with cervical dystonia.
  Jankovic J, Schwartz M, Adams AM, 20th International Congress of Parkinson’s Disease and Movement Disorders, Berlin, Germany, 1/23/2016
• Treatment of blepharospasm with apraclonidine.
  Vijayakumar D, Wijemanne S, Jankovic J, 20th International Congress of Parkinson's Disease and Movement Disorders, Berlin, Germany, 1/23/2016
• Apraclonidine in the treatment of ptosis.
  Wijemanne S, Vijayakumar D, Jankovic J, 20th International Congress of Parkinson's Disease and Movement Disorders, Berlin, Germany, 1/23/2016
• A pilot study of deutetrabenazine in tics associated with Tourette syndrome.
  Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D, 20th International Congress of Parkinson's Disease and Movement Disorders, Berlin, Germany, 1/21/2016
• A pilot study of deutetrabenazine in tics associated with Tourette syndrome.
  Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, Stamler D, 68th Annual Meeting of the AAN, Vancouver, British Columbia, Canada, 1/16/2016
• A phase 2, openlabel, dose-escalating study to evaluate the safety and preliminary efficacy of Daxibotulinumtoxina for injection (RT002) in isolated cervical dystonia.
  Comella CL, Brashear A, Jankovic J, Patel AT, Truong DD, Chung CY, Rubio RG, Toxicon; TOXINS Congress, Madrid, Spain, 1/1/2016
• Clinical relevance of treatment with onabotulinumtoxina in patients with cervical dystonia: results from the CD PROBE study.
  Dashtipour K, Mari Z, Jankovic J, Adler CH, Schwartz M, Brin MF, Toxicon; TOXINS Congress, Madrid, Spain, 1/1/2016
• Potential new uses of botulinum toxin injections in movement disorders.
  Jankovic J, Toxicon; TOXINS Congress, Madrid, Spain, 1/1/2016
• Predictors of onabotulinumtoxina response in patients with cervical dystonia.
  Jankovic J, Schwartz M, Adams AM, Toxicon; TOXINS Congress, Madrid, Spain, 1/1/2016
• Join now to see all

Lectures

• New Uses of Botulinum Toxin in Movement Disorders 
  Madrid, Spain - 1/18/2017
• Dyskinesia: What to do about moving too much? 
  1/21/2016
• Cannabis in Parkinson’s disease 
  Charlotte, NC - 1/5/2016
• Post-traumatic dystonia and complex regional pain syndrome 
  Rockville, MD - 1/2/2016
• Hyperkinetic Movement Disorders 
  Cartagena, Colombia - 1/24/2015
• Autoimmune Movement Disorders 
  Berlin, Germany - 1/23/2015
• The role of a mentor in life and in career 
  Berlin, Germany - 1/23/2015
• Beyond Shaking and Slowness 
  1/2/2015
• Innovations in Parkinson’s Disease: Past, present & Future 
  Houston, TX - 1/10/2014
• Current Neurology 
  Baylor College of Medicine, Houston, TX - 1/1/2014
• 23rd Annual Course: A Comprehensive Review of Movement Disorders for the Clinical Practitioner 
  Columbia University, Aspen, Colorado - 7/28/2013
• Comprehensive Board Review of Movement Disorders for the Clinical Practitioner 
  Columbia University, Aspen, Colorado - 7/30/2012
• Advances in Movement Disorders 
  New York, NY - 1/25/2012
• Parkinson’s Disease and Movement Disorders: Moving Forward, Breaking Boundaries 
  Baylor College of Medicine - 1/1/2010
• Tetrabenazine: Pharmacology and Clinical Use 
  Baltimore, MD - 1/20/2009
• Huntinton’s Disease: The past, present and future. 
  Cleveland, OH - 1/16/2009
• Parkinson’s Disease: Breakthrough Research and Treatments 
  Baylor College of Medicine, Houston, TX - 1/11/2009
• An Update on Tourette Syndrome 
  Baylor College of Medicine, Houston, TX - 1/5/2009
• Treatment of Parkinson’s Disease 
  1/1/2009
• Pre-clinical Biomarkers and Modifiers of Parkinson’s Disease 
  Houston, TX - 1/18/2008
• Is Levodopa the Magic Bullet for Parkinson’s Disease? 
  Nurnberg, Germany - 1/4/2008
• Multidiciplinary Advances in Tourette’s Syndrome and Implicatios for Clinical Practice 
  Bari, Italy - 1/4/2008
• Updates for Neurologists 
  New York, NY - 1/3/2008
• NYU Neurology Day 2008 
  New York, NY - 1/3/2008
• Clinical usefulness of botulinum toxin 
  1/1/2008
• Join now to see all

Other

• Skin in Parkinson’s disease. 
  Jankovic J, HAPS Newsletter
  1/1/2017
• Etiology and pathogenesis of Parkinson's disease. 
  Jankovic J, UpToDate in Neurology
  Wellesley, MA - 1/1/2017
• Hyperkinetic movement disorders. 
  Jankovic J, UpToDate in Pediatrics
  http://www.uptodateonline.com
  Wellesley, MA - 1/1/2017
• Hypokinetic movement disorders. 
  Jankovic J, UpToDate in Pediatrics
  http://www.uptodateonline.com
  Wellesley, MA - 1/1/2017
• Orthostatic Tremor Resource 
  Jankovic J
  http://www.orthostatictremor.org/
  Houston, TX - 1/10/2016
• Parkinson’s disease and music. 
  Jankovic J., HAPS Happening Newsletter
  1/1/2016
• Marijuana and Parkinson’s disease. 
  Jankovic J, HAPS Newsletter
  1/1/2015
• Eldad Melamed. In Memoriam. 
  Jankovic J, Moving Along
  1/1/2015
• NKX2-1-Related Disorders. 
  Patel NJ, Jankovic J (Pagon RA, Adam MP, Bird TD, et al., editors), GeneReviews
  http://www.ncbi.nlm.nih.gov/books/NBK185066/
  University of Washington, Seattle, WA - 1/20/2014
• Huntington’s disease 
  Jankovic J, Aspen Course on Parkinson’s Disease and Other Movement Disorders
  http://www.medscape.org/viewarticle/839235
  1/1/2014
• Parkinson’s Disease: Medical and Surgical Treatment. Clinical Insights E-Book Series 
  Jankovic J, ed, Future Science Group
  www.futuremedicine.com
  London, United Kingdom - 1/1/2013
• Parkinson’s Disease: Diagnosis, Motor Symptoms and Non-Motor Features. Clinical Insights E-Book Series 
  Jankovic J, ed, Future Science Group
  www.futuremedicine.com
  London, United Kingdom - 1/1/2013
• Ha A, Jankovic J 
  Ha A, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
  www.medlink.com
  San Diego, CA - 1/1/2013
• Spasmodic dysphonia. 
  Ha A, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
  www.medlink.com
  San Diego, CA - 1/1/2013
• Corticobasal degeneration. 
  Frank SA, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
  www.medlink.com
  San Diego, CA - 1/1/2012
• Paroxysmal dyskinesias. 
  Ha A, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
  www.medlink.com
  San Diego, CA - 1/1/2012
• Functional anatomy and pharmacology of the basal ganglia. 
  Hanna PA, Onasanya O, Mink J, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
  www.medlink.com
  San Diego, CA - 1/1/2012
• Childhood movement disorders. 
  Jimenez-Shahed J, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
  www.medlink.com
  San Diego, CA - 1/1/2012
• Movement disorders emergencies. 
  Patel N, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
  www.medlink.com
  San Diego, CA - 1/1/2012
• Neuro-ophthalmology of movement disorders. 
  Waln O, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
  www.medlink.com
  San Diego, CA - 1/1/2012
• Hemifacial Spasm. 
  Yaltho TC, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
  www.medlink.com
  San Diego, CA - 1/1/2012
• Motor control and movement disorders 
  Tanquilli RM and Jankovic J, Neurology-Medlink, Arbor Publishing
  http://medlink.com
  La Jolla, CA - 1/1/2012
• Multiple system atrophy. 
  Fekete R, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
  www.medlink.com
  San Diego, CA - 1/1/2010
• Postraumatic movement disorders. 
  Sathornsumette S, Stacy M, Jankovic J (Greenamyre JT, editorin-chief), MedLink Neurology: MedLink Corporation
  www.medlink.com
  San Diego, CA - 1/1/2010
• Dopa-responsive dystonia. 
  Yaltho TC, Jankovic J (Greenamyre JT, editor-in-chief), MedLink Neurology: MedLink Corporation
  www.medlink.com
  San Diego, CA - 1/1/2010
• Join now to see all